Browsing by Title :

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 36061 to 36080 of 77246

This table browses all dspace content
Issue DateTitleJournal Title
1996Phantom상 내경동맥기시부 협착에 따른 혈류변화 : 자기공명혈관촬영술 디지탈감산 혈관촬영술, 전산유체역학과의 비교 Journal of the Korean Radiologist Society(대한방사선의학회지)
2005Pharaoh Ant (Monomorium pharaonis): Newly Identified Important Inhalant Allergens in Bronchial Asthma JOURNAL OF KOREAN MEDICAL SCIENCE
2020Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH) BIOMOLECULES
2021Pharmaco-proteogenomic characterization of glioblastoma Dissertation
2022Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind studyBRITISH JOURNAL OF ANAESTHESIA
2021Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT StudyCLINICAL CANCER RESEARCH
2007Pharmacodynamic characteristics and cardioprotective effects of new NHE1 inhibitorsEUROPEAN JOURNAL OF PHARMACOLOGY
2015Pharmacodynamic Estimate of Propofol-Induced Sedation and Airway Obstruction Effects in Obstructive Sleep Apnea-Hypopnea Syndrome YONSEI MEDICAL JOURNAL
2020Pharmacodynamic evaluation of YH4808 for Helicobacter pylori eradication in healthy subjects Translational and Clinical Pharmacology
2016Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapyPHARMACOGENETICS AND GENOMICS
2013Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patientsCANCER CHEMOTHERAPY AND PHARMACOLOGY
2020Pharmacogenomic Analysis Reveals CCNA2 as a Predictive Biomarker of Sensitivity to Polo-Like Kinase I Inhibitor in Gastric Cancer CANCERS
2020Pharmacogenomic analysis reveals CCNA2 as a predictive biomarker of sensitivity to polo-like kinaseⅠ inhibitor in gastric cancer Thesis
2013Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung YONSEI MEDICAL JOURNAL
2005Pharmacogenomic markers predicting toxicity and response of gemcitabine in breast cancer patients Thesis
2007Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats BRITISH JOURNAL OF PHARMACOLOGY
2021Pharmacokinetic and pharmacodynamic evaluation of local minocycline agents in treating peri-implant mucositis and peri-implantitis: An experimental in vivo study Dissertation
2023Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjectsExpert Opinion on Drug Metabolism & Toxicology
2017Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patientsJOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
2005Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocinEUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Browse

Links